Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
National Electrostatics Corporation (NEC) is a global leader in the design and manufacture of electrostatic ion beam accelerator systems. Founded in 1970, the company is best known for its Pelletron accelerators, which are utilized in a variety of scientific and industrial applications including ion implantation and ion beam analysis. In the life sciences and pharmaceutical sectors, NEC provides specialized Accelerator Mass Spectrometry (AMS) systems used for ultra-sensitive tracer studies, such as microdosing and drug metabolism (ADME) analysis. These systems allow researchers to detect carbon-14 labeled drug candidates at extremely low concentrations, significantly enhancing the safety and efficiency of early-phase clinical trials. Headquartered in Middleton, Wisconsin, NEC operates as an employee-owned company serving research laboratories and commercial facilities worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Electrostatics Corporation.